Conduritol B epoxide ≥97%, weißes Pulver

Lieferant: MP Biomedicals

Synonyme: rel-(1R,2R,3S,4S,5R,6S)-7-Oxabicyclo[4.1.0]heptane-2,3,4,5-tetraol

0215889305 0215889325
ICNA0215889305EA 210 EUR
ICNA0215889305 ICNA0215889325
Conduritol B epoxide ≥97%, weißes Pulver
Conduritol B epoxide

Conduritol B Epoxide (CBE) is a potent, irreversible inhibitor of various plant β-glucosidases and mammalian glucocerebrosidase, specific covalent inhibitor of β-glucosidase which results in the accumulation of glucocerebroside.


  • β-Glucosidase inhibitor


In vitro exposure of cells to CBE has been reported to lead to up-regulation of CD1d (cluster of differentiation 1d) expression by THP-1 cells, which is related to an increase in mRNA expression. Has been employed in in vitro and animal models for Gaucher's disease. Treatment of murine peritoneal macrophages with this inhibitor does not seem to affect lysozyme enzyme release to the medium, cell viability, or levels of intracellular lysosomal enzymes, other than the beta-glucosidase activity.


Soluble in water (25 mg/ml) and DMSO; slightly soluble in methanol. Store solutions aliquoted at -20 °C for up to 3 months.

Formel: C₆H₁₀O₅
Molecular Weight: 162,141 g/mol
Schmelzpunkt: 159…161 °C (Lit.)
Lagertemperatur: Gefrierschrank
MDL: MFCD00077326
CAS-Nummer: 6090-95-5

Bestellen

Spezifikation Testergebnisse

Identity test Passes
Purity ≥97%

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR